Mylomid Capsule 25 mg contains Lenalidomide, a powerful immunomodulatory and antineoplastic agent used for the treatment of various hematologic malignancies. Lenalidomide, a derivative of thalidomide, is designed to modulate the immune system, inhibit tumor growth, and enhance the body’s ability to target abnormal blood cells. It offers a multifaceted mechanism of action, making it highly effective in managing multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphomas.

Lenalidomide works by stimulating T-cells and natural killer (NK) cells to destroy malignant cells, inhibiting cytokines that promote tumor growth, and blocking angiogenesis (formation of new blood vessels that feed tumors). This combination of immune modulation and direct antitumor activity helps slow disease progression, improve survival rates, and enhance quality of life for patients under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Mylomid Capsule 25 mg is indicated for:

• Multiple myeloma – newly diagnosed or relapsed/refractory, often in combination with dexamethasone or other therapies

• Myelodysplastic syndromes (MDS) – particularly in patients with deletion 5q chromosomal abnormality

• Mantle cell lymphoma – as part of combination therapy for eligible patients

• Other hematologic malignancies as determined by a hematologist or oncologist

This higher-dose capsule is typically prescribed when a stronger regimen is required, or during specific phases of treatment to achieve optimal therapeutic outcomes.

Key Benefits

• Targets abnormal blood cells while enhancing immune system activity

• Inhibits tumor growth and slows disease progression

• Reduces the risk of recurrence in multiple myeloma and MDS

• Supports combination therapy regimens to improve overall treatment efficacy

• Oral administration allows convenient outpatient treatment

By addressing both the malignant cells and the underlying immune environment, Mylomid Capsule 25 mg offers comprehensive disease control for patients with serious hematologic conditions.

Dosage and Administration

• The dose and schedule depend on the patient’s condition, treatment plan, and response, and must be determined by a registered hematologist or oncologist.

• Capsules are taken once daily, with or without food, at the same time each day.

• Swallow capsules whole; do not crush, chew, or open them.

• Regular monitoring of blood counts, kidney and liver function, and other parameters is essential to ensure safety and effectiveness.

Strict adherence to the prescribed regimen is critical to minimize complications and maximize treatment benefits.

Precautions

• Pregnancy and contraception: Lenalidomide can cause severe birth defects. Both male and female patients must follow strict contraception guidelines before, during, and after treatment.

• Use caution in patients with kidney or liver impairment.

• Monitor for blood clots, infections, or abnormal blood counts.

• Inform your healthcare provider about all medications to avoid drug interactions.

• Avoid live vaccines during treatment.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Mylomid Capsule 25 mg is generally effective but may cause:

• Fatigue or weakness

• Low blood counts (anemia, neutropenia, thrombocytopenia)

• Nausea, constipation, or diarrhea

• Skin rash or itching

• Increased risk of infections or blood clots

Frequent medical supervision is necessary to promptly identify and manage adverse effects.

Storage Instructions

Store below 30°C in a dry place, protected from light and moisture. Keep capsules in the original packaging and out of reach of children.

Mylomid Capsule 25 mg (Lenalidomide) is a high-potency oral therapy for hematologic cancers, offering immunomodulatory, anti-angiogenic, and antitumor effects that help manage disease progression and improve patient outcomes under medical supervision.